<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00732979</url>
  </required_header>
  <id_info>
    <org_study_id>NNR-01</org_study_id>
    <nct_id>NCT00732979</nct_id>
  </id_info>
  <brief_title>Infrahepatic Inferior Vena Cava Clamping During Hepatectomy</brief_title>
  <acronym>IVC CLAMP</acronym>
  <official_title>IVC CLAMP: Infrahepatic Inferior Vena Cava Clamping During Hepatectomy - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraoperative blood loss is a major concern during hepatic resection, as it has been shown&#xD;
      to adversely affect patients' perioperative outcome. Reduction of central venous pressure&#xD;
      during parenchymal transection has been shown to effectively lower liver hemorrhage. While&#xD;
      CVP reduction is mainly achieved via fluid restriction and diuretics, dehydration may impair&#xD;
      organ function. Moreover, it may lead to hemodynamic instability, particularly in case of&#xD;
      severe bleeding. For this reason the technique of infrahepatic inferior vena cava clamping&#xD;
      has been suggested which is able to lower CVP without the need for fluid restriction.&#xD;
&#xD;
      In the present study the two strategies to reduce CVP and by this intraoperative bleeding,&#xD;
      namely fluid restriction and inferior vena cava clamping are compared with intraoperative&#xD;
      blood loss as primary endpoint.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>End of operation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">152</enrollment>
  <condition>Hemorrhage</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infrahepatic inferior vena cava clamping The inferior vena cava is circumferentially dissected below the liver and clamped with a vascular clamp. Patients in this study group will receive intravenous volume for maintenance of fluid hemostasis according to local standards.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this study group undergo hepatic resection following current standards of the Departments of Surgery and Anesthesiology, University of Heidelberg. Current practice consists of no type of vascular control in combination with CVP reduction below &lt; 5mmHg. CVP reduction is mainly attained using restricted intravenous fluid administration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Infrahepatic inferior vena cava clamping</intervention_name>
    <description>The inferior vena cava is circumferentially dissected below the liver and clamped with a vascular clamp. Patients in this study group will receive intravenous volume for maintenance of fluid hemostasis according to local standards.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No infrahepatic inferior vena cava clamping</intervention_name>
    <description>Patients in this study group undergo hepatic resection following current standards of the Departments of Surgery and Anesthesiology, University of Heidelberg. Current practice consists of no type of vascular control in combination with CVP reduction below &lt; 5mmHg. CVP reduction is mainly attained using restricted intravenous fluid administration.</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years&#xD;
&#xD;
          -  Scheduled for elective hepatic resection due to any reason&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) score I to III&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical conditions exposing patient at increased risk for not tolerating liver&#xD;
             resection:&#xD;
&#xD;
          -  Cirrhosis (Child-Pugh B and C)&#xD;
&#xD;
          -  (Hereditary) coagulopathy&#xD;
&#xD;
          -  Medical conditions exposing patient at increased risk for not tolerating this trial's&#xD;
             study interventions:&#xD;
&#xD;
          -  Severe heart disease (e.g. severe CAD requiring intervention, NYHA IV)&#xD;
&#xD;
          -  Pulmonary hypertension&#xD;
&#xD;
          -  Renal insufficiency (serum creatinin &gt;2mg/dl or &gt;177Âµmol/l; conversion factor 88.4 or&#xD;
             requiring dialysis)&#xD;
&#xD;
          -  Severe hypernatremia (serum sodium &gt;155mmol/l)&#xD;
&#xD;
          -  Severe hyperchloremia&#xD;
&#xD;
          -  For female subjects: pregnancy and lactation&#xD;
&#xD;
          -  Impaired mental state or language problems&#xD;
&#xD;
          -  Participation in other clinical trials or observation period of competing trials&#xD;
             interfering with the endpoints of this trial&#xD;
&#xD;
          -  Former participation in the clinical trial&#xD;
&#xD;
          -  Expected lack of compliance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of General, Visceral and Transplantation Surgery, University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <study_first_submitted>August 7, 2008</study_first_submitted>
  <study_first_submitted_qc>August 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2008</study_first_posted>
  <last_update_submitted>May 16, 2013</last_update_submitted>
  <last_update_submitted_qc>May 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Nuh Rahbari</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Elective</keyword>
  <keyword>hepatic</keyword>
  <keyword>resection</keyword>
  <keyword>due to any</keyword>
  <keyword>reason.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

